CompaniesAltair Clinical

Altair Clinical

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

195

By Phase

PHASE2: 2

By Status

RECRUITING: 1COMPLETED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT05092776
NCT06528678
NCT05190991
Hover over trial bars to see details

Recent Trials

NCT05190991Collaborator
Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
PHASE2Recruiting
60 participants
Started: Oct 5, 2021 · Completed: Jan 31, 2029
NCT06528678Lead Sponsor
Patients Outcomes of a Monofocal Intraocular Lens Designed for Monovision
N/ACompleted
51 participants
Started: Apr 30, 2021 · Completed: Oct 24, 2023
NCT05092776Collaborator
Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
PHASE2Active, not recruiting
84 participants
Started: Apr 29, 2021 · Completed: Oct 30, 2025